Biography

Alla Digilova is a partner in the Capital Markets and Securities Practice Group in Haynes Boone’s New York office.

Alla Digilova focuses her practice on capital markets transactions, securities regulation, and corporate governance, advising public and private companies, investment banks, and institutional investors. Alla’s extensive experience spans a wide range of public and private securities offerings, including initial and secondary offerings of equity and convertible securities, “at-the market” offerings, rights offerings, registered direct offerings, high-yield and investment debt offerings, and private investments in public equity (PIPEs). Alla also advises clients on corporate transactions of varying complexity, including cross-border listings, mergers and acquisitions, reverse mergers, de-SPAC transactions, spin-offs, and direct listings. In addition, Alla serves as outside counsel to numerous public company clients with respect to corporate governance issues, compliance with NYSE and NASDAQ requirements, SEC reporting and compliance with the U.S. federal securities laws, as well as general corporate matters.

Alla's clients come from a diverse set of industries, including life sciences, mining, consumer goods, and technology. Her market-leading work has earned her recognition as a "Rising Star" in Securities and Corporate Governance by Super Lawyers in 2024-2025 and the ABA's “Top 40 Young Lawyers” Award in 2024.

Alla is actively involved in community and professional initiatives, serving on the board of Harvard Law School Association of New York, the board of COJECO (Council of Jewish Émigré Community Organizations), and the Editorial Board of Women Lawyers Journal of National Association of Women Lawyers. In recognition of her commitment to community and professional engagement, Alla was named a finalist for the 2025 American Lawyer Industry Awards in Young Lawyer of the Year — Beyond Practice category.

Alla earned her law degree from Harvard Law School, where she served as the Legal Fellow at Multi-Regional Clinical Trials Center at Harvard University and a Board Member of Harvard Law and International Development Society.

Expand All